Exponent Inc. has announced a management change with the appointment of Jon Fryzek, Ph.D., M.P.H., as a principal scientist in the Health Sciences practice. With over 30 years of experience in epidemiological research, Dr. Fryzek will enhance Exponent's capabilities in real-world and clinical evidence, focusing on occupational, environmental, and pharmaco-epidemiology. He will support pharmaceutical and medical device manufacturers in product development and regulatory compliance. Dr. Fryzek previously served at Exponent from 2011 to 2012.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.